Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 October 2023 | Story Dr Kwazi Magwenzi | Photo supplied
SANRAL Chair launch
The SANRAL Chair in Mathematics and Science , Prof Loyiso Jita with the Programme graduates, the PhD and Masters SANRAL Alumni at the event held on 28 September 2023 in Johannesburg, South Africa.

The South African Chapter of the South African National Roads Agency Limited (SANRAL) Chair alumni programme at the University of the Free State (UFS) was recently launched at the Silverstar Hotel and Casino in Johannesburg. The event aimed to showcase and celebrate the achievements made and lessons learnt in the programme, highlight the key elements and outputs to the Faculty of Education stakeholders and reimagine the future. The Faculty of Education has increased its footprint in Engaged Scholarship activities, aligning itself with the UFS Vision 130. Multiple stakeholders and community partners were invited to witness the outstanding achievements of this programme.

Since its inception in 2014, the SANRAL Chair has produced over 40 PhD graduates in three countries, namely South Africa, Lesotho, and Zimbabwe. One of the key goals of Vision 130 is for the UFS to be regionally engaged and to contribute to pressing societal needs. This involves knowledge generation that contributes to local and regional development and building sustainable partnerships. The PhD and Masters graduates have become a highly valued human resource in the South African education system and the region, and are now positioned as leaders in Institutions of higher learning in South Africa, Lesotho, and Zimbabwe.

The SANRAL Chair currently supervises a cohort of doctoral and master's students,  providing guidance in mathematical research and publications. The internship programme represents SANRAL's commitment to building skilled capacity in communities, along with driving social and economic transformation. SANRAL has also identified common challenges faced by Small, Medium, and Micro-sized Enterprises (SMMEs) in its projects and has implemented training programmes to address these issues. 

South Africa has implemented a range of programmes designed to achieve Sustainable Development Goal 1 (SDG 1), which includes land reform, agriculture, free higher education and growth. Despite the significant progress made on South Africa’s developmental journey since the advent of democracy in 1994, the country remains one of the most unequal societies in the world. Achieving the SDGs is, therefore, in South Africa’s best interest as the country pursues the vision of a united, non-racial, non-sexist, and prosperous nation living in harmony with itself and the rest of the world. 

As South Africa looks ahead to 2030, it seeks to build on the substantial progress achieved thus far, and on the robust policy, legislative, and planning foundation. The focus will be on consolidating and expanding the many areas where public welfare and development are at the forefront. 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept